Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

Background Metastatic phyllodes tumors have poor prognosis with median overall survival of 11.5 months. The objective of this study is to identify prognostic factors and the best options for management of metastatic malignant phyllode tumors (MMPTs). Patients and Methods A multicentric retrospective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2020-05, Vol.27 (5), p.1693-1699
Hauptverfasser:	Neron, Mathias, Sajous, Christophe, Thezenas, Simon, Piperno-Neumann, Sophie, Reyal, Fabien, Laé, Marick, Chakiba, Camille, Penel, Nicolas, Ryckewaert, Thomas, Honoré, Charles, Bertucci, François, Monneur, Audrey, Salas, Sébastien, Duffaud, Florence, Saada-Bouzid, Esma, Isambert, Nicolas, Brahmi, Mehdi, Ray-Coquard, Isabelle, Blay, Jean-Yves, Firmin, Nelly
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Alkylating agents Alkylating Agents - therapeutic use Anthracycline Breast Neoplasms - mortality Breast Neoplasms - therapy Breast Oncology Cellular Biology Chemotherapy Chemotherapy, Adjuvant Female France - epidemiology Humans Life Sciences Male Medical prognosis Medicine Medicine & Public Health Metastases Metastasis Middle Aged Multivariate analysis Neoplasm Metastasis - therapy Oncology Patients Phyllodes Tumor - mortality Phyllodes Tumor - therapy Prognosis Radiation therapy Retrospective Studies Sarcoma Surgery Surgical Oncology Surgical Procedures, Operative Survival Survival Analysis Tumors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!